Next Article in Journal
Cellular and Molecular Immunity to Influenza Viruses and Vaccines
Next Article in Special Issue
Correlates of Breakthrough SARS-CoV-2 Infections in People with HIV: Results from the CIHR CTN 328 Study
Previous Article in Journal
Characteristics and Outcomes for Recipients of NVX-CoV2373: A Real-World Retrospective Study in Germany
Previous Article in Special Issue
SARS-CoV-2 Neutralizing Antibodies in Three African Countries Following Multiple Distinct Immune Challenges
 
 
Article

Article Versions Notes

Vaccines 2024, 12(4), 388; https://doi.org/10.3390/vaccines12040388
Action Date Notes Link
article xml file uploaded 6 April 2024 12:04 CEST Original file -
article xml uploaded. 6 April 2024 12:04 CEST Update https://www.mdpi.com/2076-393X/12/4/388/xml
article pdf uploaded. 6 April 2024 12:04 CEST Version of Record https://www.mdpi.com/2076-393X/12/4/388/pdf
article supplementary file uploaded. 6 April 2024 12:04 CEST - https://www.mdpi.com/2076-393X/12/4/388#supplementary
article html file updated 6 April 2024 12:07 CEST Original file -
article supplementary file uploaded. 7 April 2024 04:41 CEST - https://www.mdpi.com/2076-393X/12/4/388#supplementary
article html file updated 7 April 2024 04:42 CEST Update https://www.mdpi.com/2076-393X/12/4/388/html
Back to TopTop